CN102028876A - Liquid Chinese medicine for treating hyperosteogeny - Google Patents

Liquid Chinese medicine for treating hyperosteogeny Download PDF

Info

Publication number
CN102028876A
CN102028876A CN2010106022788A CN201010602278A CN102028876A CN 102028876 A CN102028876 A CN 102028876A CN 2010106022788 A CN2010106022788 A CN 2010106022788A CN 201010602278 A CN201010602278 A CN 201010602278A CN 102028876 A CN102028876 A CN 102028876A
Authority
CN
China
Prior art keywords
root
hyperosteogeny
herba
liquid
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2010106022788A
Other languages
Chinese (zh)
Other versions
CN102028876B (en
Inventor
赵龙山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201010602278 priority Critical patent/CN102028876B/en
Publication of CN102028876A publication Critical patent/CN102028876A/en
Application granted granted Critical
Publication of CN102028876B publication Critical patent/CN102028876B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a liquid Chinese medicine for treating hyperosteogeny, relates to the field of Chinese patent medicines, and solves the problems that the conventional medicament for treating the hyperosteogeny used by people has toxic and side effects, cannot radically treat the hyperosteogeny or is higher in cost, and the like. The liquid Chinese medicine for treating hyperosteogeny is prepared by the following steps of: screening herbal raw material medicaments, namely primula forbesii, thin evodia twig and leaf, rhizoma paridis, root of Kwangsi Jasminorange, rose mallow root, herb of denseflower bulbophyllum, lysimachia fortunei and isodon glaucocalyx kudo to remove impurities, washing, cutting into pieces, putting the materials together according to a ratio, adding a proper amount of water and soaking for 24 to 30 hours; and boiling to the temperature of 100 DEG C, continuously decocting for 20 to 30 minutes, and filtering out the liquid medicine to prepare the liquid Chinese medicine. The liquid Chinese medicine for treating hyperosteogeny has short course of treatment, no toxic or side effect, low possibility of recrudescence and rich medicine sources and is low in cost.

Description

A kind of herb liquid for the treatment of hyperosteogeny
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of hyperosteogeny, particularly relate to a kind of external Chinese medicinal liquid for the treatment of hyperosteogeny.
Background technology
Because people often are subjected to wind, cold or damp and hot invasion and attack in daily life, work, perhaps be subjected to wound and cause local aseptic inflammation or the edema of taking place, blood circulation is obstructed, the new bone that makes cartilage destroyed back perichondrium hyperplasia and produce, form bony spur, hyperosteogeny after ossified, the traditional Chinese medical science is commonly referred to as arthromyodynia.Doctor trained in Western medicine does not still have effective medicine to hyperosteogeny at present, often adopts anti symptom treatment, takes the medicine of some antipyretic-antalgics during as pain, numbness person can select vitamin B group class medicine for use, but facts have proved that these Therapeutic Method are all undesirable, just take stopgap measures and do not effect a permanent cure that the state of an illness easily recurs.The patient serious to hyperosteogeny adopts operative treatment, but the expense height, safety is given birth to difference and also easily recurrence.Though also there is the Chinese patent medicine of some treatment hyperosteogenys traditional Chinese medical science aspect, the course of treatment is long, weak curative effect, and the expense height does not reach ideal effect.
Summary of the invention
The objective of the invention is provides a kind of cost low in order to overcome deficiency of the prior art, and curative effect is obvious, the external herb liquid of short treating period, the treatment hyperosteogeny that has no side effect.
For achieving the above object, the invention provides a kind of herb liquid for the treatment of gastropathy, made by following material medicine, its weight portion is:
Primula forbesii Franch. 62~72 3 bifurcation bitter root 70~80
Rhizoma Paridis root 70~80 Radix Murrayaes 75~85
Urena lobata Linn root 85~95 Herba Bulbophylli Odoratissims 145~155
Herba Lysimachiae Fortunei root 145~155 Herba Rabdosiae glaucocalycis herbs 165~175
Water is an amount of.
The composition by weight of each material medicine of optimum formula of the present invention is:
Primula forbesii Franch. 67 3 bifurcation bitter root 75
Rhizoma Paridis root 75 Radix Murrayaes 80
Urena lobata Linn root 90 Herba Bulbophylli Odoratissims 150
Herba Lysimachiae Fortunei root 150 Herba Rabdosiae glaucocalycis herbs 170
Water is an amount of.
The preparation method of the herb liquid of treatment hyperosteogeny comprises the steps:
(1) primula forbesii Franch., three bifurcation bitter root, Rhizoma Paridis root, Radix Murrayae, Urena lobata Linn root, Herba Bulbophylli Odoratissim, Herba Lysimachiae Fortunei root, Herba Rabdosiae glaucocalycis herb material medicine are removed impurity afterwash, chopping through screening respectively;
(2) material medicine after will cleaning, shredding is put together in described ratio and is added suitable quantity of water immersion 24~30 hours, it is boiled after 100 ℃ again and continues to decoct 20~30 minutes, leaches medicinal liquid and promptly gets this medicinal liquid.
During with herb liquid of the present invention, at painful area once with the erasing in a day of this herb liquid, twice medication of one-time continuous, after the first pass medicine was done, erasing was treated for second time to be aided with maneuvers such as massage, massage again after medicine is done again, and one month is a course of treatment, medication is decided on state of an illness weight, general three days to five days can take effect, and the lighter can fully recover in ten days to 15 days, and weight person can cure one or two course of treatment.
The material medicine mechanism that the present invention adopts is as follows:
Primula forbesii Franch. acrid in the mouth, cold, heat-clearing and toxic substances removing, expelling wind and removing dampness, promoting blood circulation and stopping pain; Three bifurcation bitter root bitter in the mouth, cold, heat-clearing and toxic substances removing, antiinflammatory detumescent, phlegm reduction of blood circulation promoting; Rhizoma Paridis root bitter in the mouth, cold has little poison, heat-clearing and toxic substances removing, mass dissipating and swelling eliminating; Radix Murrayae flavor temperature, bitter, expelling wind and removing dampness, and stomach and alleviating pain, blood circulation promoting and blood stasis dispelling; Urena lobata Linn root bitter in the mouth, suffering, flat, expelling wind and removing dampness, and stomach and alleviating pain, promoting tissue regeneration by removing blood stasis; Herba Bulbophylli Odoratissim is lightly seasoned, flat, removing heat from the lung and dissipating phlegm, relaxing muscles and tendons to promote blood circulation, anti-inflammatory analgetic; Herba Lysimachiae Fortunei root bitter in the mouth, flat, heat-clearing and toxic substances removing, inducing diuresis to remove edema, wind-expelling pain-stopping, blood circulation promoting competent silt; Herba Rabdosiae glaucocalycis herb bitter in the mouth, cold, heat-clearing and toxic substances removing, cooling blood for hemostasis, reducing swelling and alleviating pain, liver heat removing gallbladder, damp eliminating jaundice eliminating.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
Therefore 1, because the present invention has adopted said herbal medicine to carry out compatibility, it is obvious to treat the hyperosteogeny curative effect, short treating period, has alleviated the painful of patient and has been difficult for recurrence.
2, the present invention is medicine for external use and the side effect of property of medicine moderate notoxic, can not cause damage to stomach, the heart, liver, kidney.
3, material medicine of the present invention source is abundant, manufacture method is simple and easy to do, safe in utilization, with low cost.
The present invention through 1979 so far the application examples of 8768 routine patient's clinical treatments further specify herb liquid of the present invention to the treatment sciatica therapeutic effect.
For showing the therapeutic effect of herb liquid of the present invention, as follows through clinical test results to hyperosteogeny:
Hyperosteogeny of cervical vertebra patient 4216 examples, male's 1810 examples wherein, women's 2406 examples, the age, the course of disease was 1 month~6 years at 25~68 years old, with 3778 routine patients' recoveries from illness are wherein arranged behind this medicine, did not see recurrence, 210 routine patients have significant curative effect.
Lumbar vertebra hyperosteogeny patient 2546 examples, male's 1325 examples wherein, women's 1221 examples, the age, the course of disease was 1 month~4 years at 30~70 years old, with 2356 routine patients' recoveries from illness are wherein arranged behind this medicine, did not see recurrence, 190 routine patients have significant curative effect.
Other position hyperosteogeny patient 2006 examples, male's 956 examples wherein, women's 1050 examples, the age, the course of disease was 1 month~3 years at 28~65 years old, with 1710 routine patients' recoveries from illness are wherein arranged behind this medicine, did not see recurrence, 120 routine patients have significant curative effect.
The clinical data summary sheet:
Title Case Recovery from illness Significant curative effect Cure rate
Hyperosteogeny of cervical vertebra 4216 3778 210 90%
Lumbar vertebra hyperosteogeny 2546 2356 190 93%
Other position hyperosteogeny 2006 1710 120 85%
The specific embodiment
Embodiment 1: primula forbesii Franch. 62 gram, three bifurcation bitter root, 70 grams, Rhizoma Paridis root 70 grams, Radix Murrayae 75 grams, Urena lobata Linn that will remove impurity afterwash, chopping put together at root 85 grams, Herba Bulbophylli Odoratissim 145 grams, Herba Lysimachiae Fortunei root 145 grams, Herba Rabdosiae glaucocalycis herb 165 grams and added suitable quantity of water and soaked 24~30 hours, it boiled to continue to decoct after 100 ℃ to leach after 20~30 minutes more promptly to get this medicinal liquid.
Embodiment 2: primula forbesii Franch. 67 gram, three bifurcation bitter root, 75 grams, Rhizoma Paridis root 75 grams, Radix Murrayae 80 grams, Urena lobata Linn that will remove impurity afterwash, chopping put together at root 90 grams, Herba Bulbophylli Odoratissim 150 grams, Herba Lysimachiae Fortunei root 150 grams, Herba Rabdosiae glaucocalycis herb 170 grams and added suitable quantity of water and soaked 24~30 hours, it boiled to continue to decoct after 100 ℃ to leach after 20~30 minutes more promptly to get this medicinal liquid.
Embodiment 3: primula forbesii Franch. 72 gram, three bifurcation bitter root, 80 grams, Rhizoma Paridis root 80 grams, Radix Murrayae 85 grams, Urena lobata Linn that will remove impurity afterwash, chopping put together at root 95 grams, Herba Bulbophylli Odoratissim 155 grams, Herba Lysimachiae Fortunei root 155 grams, Herba Rabdosiae glaucocalycis herb 175 grams and added suitable quantity of water and soaked 24~30 hours, it boiled to continue to decoct after 100 ℃ to leach after 20~30 minutes more promptly to get this medicinal liquid.

Claims (3)

1. a herb liquid for the treatment of hyperosteogeny is characterized in that, is made by following material medicine, and its weight portion is:
Primula forbesii Franch. 62~72 3 bifurcation bitter root 70~80
Rhizoma Paridis root 70~80 Radix Murrayaes 75~85
Urena lobata Linn root 85~95 Herba Bulbophylli Odoratissims 145~155
Herba Lysimachiae Fortunei root 145~155 Herba Rabdosiae glaucocalycis herbs 165~175
Water is an amount of.
2. the herb liquid of treatment hyperosteogeny according to claim 1 is characterized in that, the composition by weight of described material medicine is:
Primula forbesii Franch. 67 3 bifurcation bitter root 75
Rhizoma Paridis root 75 Radix Murrayaes 80
Urena lobata Linn root 90 Herba Bulbophylli Odoratissims 150
Herba Lysimachiae Fortunei root 150 Herba Rabdosiae glaucocalycis herbs 170
Water is an amount of.
3. the preparation method of the herb liquid of treatment hyperosteogeny according to claim 1 is characterized in that, comprises the steps:
(1) primula forbesii Franch., three bifurcation bitter root, Rhizoma Paridis root, Radix Murrayae, Urena lobata Linn root, Herba Bulbophylli Odoratissim, Herba Lysimachiae Fortunei root, Herba Rabdosiae glaucocalycis herb material medicine are removed impurity afterwash, chopping through screening respectively;
(2) material medicine after will cleaning, shredding is put together in described ratio and is added suitable quantity of water immersion 24~30 hours, it is boiled after 100 ℃ again and continues to decoct 20~30 minutes, leaches medicinal liquid and promptly gets this medicinal liquid.
CN 201010602278 2010-12-14 2010-12-14 Liquid Chinese medicine for treating hyperosteogeny Expired - Fee Related CN102028876B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201010602278 CN102028876B (en) 2010-12-14 2010-12-14 Liquid Chinese medicine for treating hyperosteogeny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201010602278 CN102028876B (en) 2010-12-14 2010-12-14 Liquid Chinese medicine for treating hyperosteogeny

Publications (2)

Publication Number Publication Date
CN102028876A true CN102028876A (en) 2011-04-27
CN102028876B CN102028876B (en) 2013-06-12

Family

ID=43882688

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201010602278 Expired - Fee Related CN102028876B (en) 2010-12-14 2010-12-14 Liquid Chinese medicine for treating hyperosteogeny

Country Status (1)

Country Link
CN (1) CN102028876B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102600272A (en) * 2012-04-11 2012-07-25 苏贵安 Traditional Chinese medicine for treatment of orthopedic disease

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
凌元仁: "中西医结合治疗毒蛇咬伤56 例", 《实用中西医结合临床》 *
刘 毅: "傣医药治疗皮肤病拾萃", 《中国民族医药杂志》 *
彭朝忠: "澜沧拉祜族民间验方录", 《中国民族医药杂志》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102600272A (en) * 2012-04-11 2012-07-25 苏贵安 Traditional Chinese medicine for treatment of orthopedic disease
CN102600272B (en) * 2012-04-11 2013-10-09 苏贵安 Traditional Chinese medicine for treatment of orthopedic disease

Also Published As

Publication number Publication date
CN102028876B (en) 2013-06-12

Similar Documents

Publication Publication Date Title
CN103055052B (en) Cream for treating burn and scald and preparation method of cream
CN103316315B (en) Cooling paste
CN102125664B (en) Chinese medicinal preparation for treating cervical spondylosis
CN102028876B (en) Liquid Chinese medicine for treating hyperosteogeny
CN101274045B (en) Exterior-applied medicament for treating psoriasis
CN101190293A (en) Traditional Chinese medicine liquid for treating hyperosteogeny
CN104324205A (en) Traditional Chinese medicine composition for treating heart diseases
CN104288503A (en) Traditional Chinese medicine wine capable of tonifying qi and kidney
CN102068545B (en) Chinese medicinal liquid for treating stomach diseases
CN103768408A (en) Medicine for preventing and treating pains after operations due to anorectal diseases
CN104225245B (en) Treat scrofulous Chinese medicine composition
CN101607007B (en) Traditional Chinese medicine preparation for treating cerebral circulation insufficiency
CN106361840A (en) Traditional Chinese medicine composite used for treating rheumatism and preparing method thereof
CN100534515C (en) Traditional Chinese medicine liquid for treating stomach disease
CN106138629A (en) The medicine of a kind of cure scapulohumeral periarthritis and preparation method
CN102068615B (en) Chinese medicinal liquid for treating sciatica
CN104857458B (en) A kind of Traditional Chinese medicine for decreasing blood sugar combination preparation and preparation method thereof
CN105560753A (en) Medicine for curing scapulohumeral periarthritis and preparing method
CN104383196A (en) Traditional Chinese medicine preparation for treating closed fracture pain
CN105288445A (en) Medicine for treating cervical bone hyperplasia
CN103948804B (en) A kind of Chinese medicine composition treating lung qi deficiency dermatitis aestivale
CN104784588A (en) Traditional Chinese medicine preparation for treating nerve headache and preparation method
CN103070998B (en) Externally-applied plaster for curing pain of rheumatic joints
CN102688382B (en) Gamene oral liquid for treating acute gastroenteritis and preparation method thereof
CN110731897A (en) pure Chinese medicinal salt moxibustion physical thermotherapy method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130612

Termination date: 20141214

EXPY Termination of patent right or utility model